Therapeutic manipulation of gut microbiota has proven valuable in the management of
ulcerative colitis and pouchitis. Despite some similarities among the various inflammatory …

Background Vedolizumab (VDZ) is an anti-integrin monoclonal antibody effective in
ulcerative colitis (UC) and Crohn's disease (CD). The aim of this study was to examine the …

Pouchitis is a common complication in patients undergoing restorative proctocolectomy for
ulcerative colitis. Therapeutic attempts include manipulations of pouch flora composition. In …

Background & Aims Pouchitis is the most common complication after ileal pouch–anal
anastomosis (IPAA). However, symptoms are not specific. The Pouchitis Disease Activity …

BACKGROUND Inflammatory bowel diseases (IBD) is a heterogenous, lifelong disease, with
an unpredictable and potentially progressive course, that may impose negative …

Introduction Crohn's disease impairs patients' perception of health and has a negative
impact on health-related quality of life. Although it is apparent that uncertainty is a significant …

Up to 30% of patients with ulcerative colitis (UC) will require surgical management. The
established surgical procedure of choice is colectomy with ileal pouch–anal anastomosis …

Background. To investigate the association between 18F-FDG (Fluorodeoxyglucose) PET
(positron emission tomography)/MRE (magnetic resonance enterography) metrics with the …

Background: Crohn's disease (CD) and ulcerative colitis (UC) are chronic, immune-
mediated inflammatory bowel diseases (IBD) affecting millions of people worldwide. IBD …

Background The incidence of vaccine-preventable disease is increasing. Several guidelines
recommend annual influenza vaccination for patients with inflammatory bowel disease …